{"id":"https://openalex.org/W1995956780","doi":"https://doi.org/10.1016/j.ejheart.2005.09.005","title":"A Statin in the Treatment of Heart Failure? Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA): Study Design and Baseline Characteristics","display_name":"A Statin in the Treatment of Heart Failure? Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA): Study Design and Baseline Characteristics","alternate_titles":[],"publication_year":2005,"publication_date":"2005-10-01","ids":{"openalex":"https://openalex.org/W1995956780","doi":"https://doi.org/10.1016/j.ejheart.2005.09.005","mag":"1995956780","pmid":"https://pubmed.ncbi.nlm.nih.gov/16227145"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejheart.2005.09.005","doi":"https://doi.org/10.1016/j.ejheart.2005.09.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejheart.2005.09.005","pdf_url":null,"source":{"id":"https://openalex.org/S87609158","display_name":"European Journal of Heart Failure","issn_l":"1388-9842","issn":["1388-9842","1879-0844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Heart Failure","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1995956780"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025930905","display_name":"JOHN K. KJEKSHUS","orcid":"https://orcid.org/0000-0003-4306-1244","observed_orcids":["https://orcid.org/0000-0003-4306-1244"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John Kjekshus","raw_affiliation_strings":["Department of Cardiology, Rikshospitalet University Hospital, University of Oslo , Sognsvannsveien 20, Oslo, 0027, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Rikshospitalet University Hospital, University of Oslo , Sognsvannsveien 20, Oslo, 0027, Norway","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109290594","display_name":"Peter Dunselman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105981","display_name":"Amphia Ziekenhuis","ror":"https://ror.org/01g21pa45","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210105981"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Dunselman","raw_affiliation_strings":["Department of Cardiology, Ampia Hospital, Breda, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Ampia Hospital, Breda, The Netherlands","institution_ids":["https://openalex.org/I4210105981"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011481852","display_name":"Malin Blideskog","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Malin Blideskog","raw_affiliation_strings":["AstraZeneca R&D , M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D , M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061065111","display_name":"Christina Eskilson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christina Eskilson","raw_affiliation_strings":["AstraZeneca R&D , M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D , M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113581005","display_name":"\u00c5ke C. Hjalmarson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u00c5ke Hjalmarson","raw_affiliation_strings":["Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital , G\u00f6teborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital , G\u00f6teborg, Sweden","institution_ids":["https://openalex.org/I2801112325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027213857","display_name":"John J.V. McMurray","orcid":"https://orcid.org/0000-0002-6317-3975","observed_orcids":["https://orcid.org/0000-0002-6317-3975"]},"institutions":[{"id":"https://openalex.org/I2801120601","display_name":"Western Infirmary","ror":"https://ror.org/02e22bh87","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I2801120601"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John V. McMurray","raw_affiliation_strings":["Department of Cardiology, Western Infirmary , Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Western Infirmary , Glasgow, UK","institution_ids":["https://openalex.org/I2801120601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035769046","display_name":"Finn Waagstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Finn Waagstein","raw_affiliation_strings":["Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital , G\u00f6teborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital , G\u00f6teborg, Sweden","institution_ids":["https://openalex.org/I2801112325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005456371","display_name":"Hans Wedel","orcid":"https://orcid.org/0000-0001-7571-0021","observed_orcids":["https://orcid.org/0000-0001-7571-0021"]},"institutions":[{"id":"https://openalex.org/I4210158614","display_name":"Nordic School of Public Health","ror":"https://ror.org/03gfs5c49","country_code":"SE","type":"education","lineage":["https://openalex.org/I4210158614"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hans Wedel","raw_affiliation_strings":["Nordic School of Public Health , G\u00f6teborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nordic School of Public Health , G\u00f6teborg, Sweden","institution_ids":["https://openalex.org/I4210158614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054815299","display_name":"Peter Wessman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Wessman","raw_affiliation_strings":["AstraZeneca R&D , M\u00f6lndal, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D , M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041045674","display_name":"John Wikstrand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Wikstrand","raw_affiliation_strings":["AstraZeneca R&D , M\u00f6lndal, Sweden","Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital , G\u00f6teborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D , M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital , G\u00f6teborg, Sweden","institution_ids":["https://openalex.org/I2801112325"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5025930905"],"corresponding_institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"],"apc_list":{"value":5300,"currency":"USD","value_usd":5300},"apc_paid":null,"fwci":17.3003,"has_fulltext":false,"cited_by_count":159,"citation_normalized_percentile":{"value":0.99392216,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"7","issue":"6","first_page":"1059","last_page":"1069"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.07509999722242355,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rosuvastatin","display_name":"rosuvastatin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.8259999752044678},{"id":"https://openalex.org/keywords/heart-failure-with-reduced-ejection-fraction","display_name":"heart failure with reduced ejection fraction","score":0.9710000157356262},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.7630000114440918},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.7049999833106995},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9750000238418579},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.9900000095367432},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.9620000123977661},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.7009999752044678},{"id":"https://openalex.org/keywords/ischemic-heart-failure","display_name":"ischemic heart failure","score":0.6629999876022339},{"id":"https://openalex.org/keywords/baseline-characteristics","display_name":"baseline characteristics","score":0.621999979019165},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9198269844055176},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.8657300472259521},{"id":"https://openalex.org/C2780499067","wikidata":"https://www.wikidata.org/wiki/Q415159","display_name":"Rosuvastatin","level":2,"score":0.8055261373519897},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7681886553764343},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.7395434975624084},{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.6897506713867188},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.6017624735832214},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5494781732559204},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5388438701629639},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3627315163612366},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068718","descriptor_name":"Rosuvastatin Calcium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005464","descriptor_name":"Fluorobenzenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D007391","descriptor_name":"International Cooperation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011336","descriptor_name":"Probability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejheart.2005.09.005","doi":"https://doi.org/10.1016/j.ejheart.2005.09.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejheart.2005.09.005","pdf_url":null,"source":{"id":"https://openalex.org/S87609158","display_name":"European Journal of Heart Failure","issn_l":"1388-9842","issn":["1388-9842","1879-0844"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Heart Failure","raw_type":"journal-article"},{"id":"pmid:16227145","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16227145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of heart failure","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W38523360","https://openalex.org/W424467158","https://openalex.org/W1500963439","https://openalex.org/W1558041704","https://openalex.org/W1973523151","https://openalex.org/W1988047864","https://openalex.org/W2005267038","https://openalex.org/W2010654921","https://openalex.org/W2012105257","https://openalex.org/W2027818413","https://openalex.org/W2028389960","https://openalex.org/W2029471511","https://openalex.org/W2031185570","https://openalex.org/W2040982433","https://openalex.org/W2041319935","https://openalex.org/W2049348368","https://openalex.org/W2052581447","https://openalex.org/W2058437840","https://openalex.org/W2078103515","https://openalex.org/W2084273906","https://openalex.org/W2086177904","https://openalex.org/W2088451948","https://openalex.org/W2091243061","https://openalex.org/W2107295258","https://openalex.org/W2111995104","https://openalex.org/W2114338526","https://openalex.org/W2129750583","https://openalex.org/W2130873593","https://openalex.org/W2133275623","https://openalex.org/W2135036166","https://openalex.org/W2135631433","https://openalex.org/W2137412139","https://openalex.org/W2146902372","https://openalex.org/W2150499586","https://openalex.org/W2152789823","https://openalex.org/W2155598961","https://openalex.org/W2157775932","https://openalex.org/W2159801354","https://openalex.org/W2160000314","https://openalex.org/W2162393927","https://openalex.org/W2168081193","https://openalex.org/W2172111517","https://openalex.org/W2322095705","https://openalex.org/W2488398174","https://openalex.org/W3191750161","https://openalex.org/W4246764494","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2406540107","https://openalex.org/W2322090840","https://openalex.org/W1998887345","https://openalex.org/W2036360994","https://openalex.org/W1983094422","https://openalex.org/W2167877479","https://openalex.org/W2063035288","https://openalex.org/W2126452437","https://openalex.org/W2439600311","https://openalex.org/W2160246219"],"abstract_inverted_index":{"BACKGROUND:":[0],"Previous":[1],"prospective":[2],"outcome":[3],"studies":[4],"of":[5,34,77,108,143,195,199,206],"statins":[6],"have":[7,140,233],"not":[8,103],"provided":[9],"any":[10],"guidance":[11],"on":[12,160],"benefit-risk":[13],"in":[14,106,123,128,215],"patients":[15,208],"with":[16,71,121,158,209],"heart":[17,75,156,213,231],"failure.":[18],"AIM:":[19],"The":[20,47],"primary":[21],"objective":[22],"is":[23,51,56,181,191],"to":[24,44,234],"determine":[25],"whether":[26],"rosuvastatin":[27],"(10":[28],"mg)":[29],"reduces":[30],"the":[31,196,200,203,219],"combined":[32],"endpoint":[33,50],"cardiovascular":[35],"mortality,":[36],"non-fatal":[37,41],"myocardial":[38,144],"infarction":[39],"or":[40,68,84,91,93,105,162,171],"stroke":[42],"(time":[43],"first":[45,48],"event).":[46],"secondary":[49],"all-cause":[52],"mortality.":[53],"METHODS:":[54],"CORONA":[55,180],"a":[57,141],"randomized,":[58],"double-blind,":[59],"placebo-controlled":[60],"trial.":[61],"Briefly,":[62],"men":[63],"and":[64,80,89,126,148,176,218],"women,":[65],"aged":[66],">":[67],"=60":[69],"years":[70,117],"chronic":[72,210],"symptomatic":[73,211],"systolic":[74,212],"failure":[76,157,214,232],"ischemic":[78],"aetiology":[79],"ejection":[81,131],"fraction":[82,132],"<":[83,92],"=0.40":[85],"(NYHA":[86,95],"class":[87,96],"III":[88],"IV)":[90],"=0.35":[94],"II)":[97],"were":[98,102],"eligible":[99],"if":[100],"they":[101],"using":[104],"need":[107],"cholesterol":[109,135],"lowering":[110],"drugs.":[111],"RESULTS:":[112],"Mean":[113],"age":[114],"was":[115],"73":[116],"(n=5016;":[118],"24%":[119],"women),":[120],"37%":[122],"NYHA":[124,129],"II":[125],"62%":[127],"III,":[130],"0.31,":[133],"total":[134],"5.2":[136],"mmol/L.":[137],"Sixty":[138],"percent":[139],"history":[142],"infarction,":[145],"63%":[146],"hypertension,":[147],"30%":[149],"diabetes.":[150],"Patients":[151],"are":[152],"well":[153],"treated":[154],"for":[155,183],"90%":[159],"loop":[161],"thiazide":[163],"diuretics,":[164],"42%":[165],"aldosterone":[166],"antagonists,":[167],"91%":[168],"ACE":[169],"inhibitor":[170],"AT-I":[172],"blocker,":[173],"75%":[174],"beta-blockers,":[175],"32%":[177],"digitalis.":[178],"CONCLUSION:":[179],"important":[182,193],"three":[184],"main":[185],"reasons:":[186],"(1)":[187],"A":[188],"positive":[189],"result":[190],"very":[192],"because":[194],"high":[197],"risk":[198],"population":[201],"studied,":[202],"increasing":[204],"prevalence":[205],"elderly":[207],"our":[216],"society,":[217],"health":[220],"economic":[221],"issues":[222],"involved.":[223],"(2)":[224],"If":[225,238],"negative,":[226],"new":[227],"mechanistic":[228],"questions":[229],"about":[230],"be":[235],"raised.":[236],"(3)":[237],"neutral":[239],"we":[240],"can":[241],"avoid":[242],"unnecessary":[243],"polypharmacy.":[244]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1995956780","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
